Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-22T07:11:14.450Z Has data issue: false hasContentIssue false

Oxypertine in Tardive Dyskinesia: An 8-week Controlled Study

Published online by Cambridge University Press:  29 January 2018

S. D. Soni
Affiliation:
Salford Health Authority, Prestwich Hospital, Bury New Rd., Prestwich M25 7BL
H. L. Freeman
Affiliation:
Salford Health Authority, Hope Hospital, Salford M6 8HD
E. M. Hussein
Affiliation:
Winwick Hospital, Warrington, Cheshire WA2 8RR

Summary

In a double-blind placebo controlled trial of oxypertine in the treatment of tardive dyskinesia, 33 patients with chronic schizophrenia received either oxypertine or placebo. At the end of eight weeks, the results showed that oxypertine was superior to placebo at a statistically significant level.

Type
Research Article
Copyright
Copyright © 1984 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bandtup, E. (1961) Tetrabenazine treatment in persisting dyskinesia caused by psychopharmacea. American Journal of Psychiatry, 118, 551–2.Google Scholar
Chien, C-P, Jurg, K. & Ross-Townsend, A. (1978) Efficacies of agents related to GABA, dopamine and acetylcholine in the treatment of tardive dyskinesia. Psychopharmacology Bulletin, 14, 2022.Google Scholar
Eckmann, F. (1968) The problems of lasting damage following long-term neuroleptic treatment. Therapie Gegeru, 107, 316–23.Google Scholar
Freeman, H. L., Soni, S. D. & Carpenter, L. (1980) A controlled trial of oxypertine in tardive dyskinesia. International Pharmacopsychiatry, 15, 281–91.Google Scholar
Kazamatsuri, H. (1980) Treatment of tardive dyskinesia with oxypertine. Comprehensive Psychiatry, 21, 352–7.Google Scholar
Villeneuve, A., Borszotmenyi, Z., Descharmbault, M. & Lachence, R. (1970) An attempt to treat postneuroleptic dyskinesia of the permanent type. Laval Médecin, 40, 832–7.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.